Cerebral Vasodilators (First of Two Parts)
NEJM 305:1508-1513, Cook,P.,et al, 1981
Treatment of the Cerebral Manifestations of Arteriosclerosis with Cyclandelate
Br J Psych 124:177, Young,J.,et al, 1974
SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
Neurol 103:e209805, Kim,H.K.,et al, 2024
Cerebral Vasodilators (Second of Two Parts)
NEJM 305:1560-1564, Cook,P.,et al, 1981